Intra-Cellular Therapies Inc (BSP:I2TC34)
R$ 84.24 0 (0%) Market Cap: 8.93 Bil Enterprise Value: 2.85 Bil PE Ratio: 0 PB Ratio: 7.86 GF Score: 32/100

Intra-Cellular Therapies Inc (BSP:I2TC34) Transcripts

  • 1